Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Pyramid Biosciences
Scientific Title
A Phase 1/2 Study of PBI-200 in Subjects With NTRK-Fusion-Positive Advanced or Metastatic Solid Tumors